Tiapride

This classification denotes an anti-dyskinesia agent, antipsychotic agent, and dopamine antagonist with the molecular formula C15H24N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LAH70H9JPH, chemically known as benzamide, n-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)- but generally known as tiapride, which bears US NIH Compound Identifier 5467. European Medicines Agency schedules Tiapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11010MIG. World Health Organization schedules tiapride in its Anatomical Therapeutic Chemical (ATC) Classification. TIAPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tiapride under HS 29242995 and SITC 51479. As of Q4 2014, TIAPRIDE remains the US FDA Preferred Term for this commodity. SMILES: S(=O)(=O)(C1CC(C(=O)NCCN(CC)CC)C(OC)CC1)C.